Phase I trial of tivantinib and sorafenib in patients with liver cancer
Phase of Trial: Phase I
Latest Information Update: 06 Oct 2009
At a glance
- Drugs Tivantinib (Primary) ; Sorafenib
- Indications Liver cancer
- Focus Therapeutic Use
- 06 Oct 2009 Status changed from planning to recruiting, according to an ArQule media release.
- 08 Apr 2009 New trial record.